Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

318
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
318
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

551
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
551
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

499
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
499
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

323
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
323
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

780
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
780
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

724
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
724

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting of nucleotide-binding proteins by HAMLET--a conserved tumor cell death mechanism.

Oncogene·2015
Same author

Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

Oncogene·2011
Same author

Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.

Acta anaesthesiologica Scandinavica·2010
Same author

TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.

European journal of clinical investigation·2008
Same author

Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection.

Kidney international·2008
Same author

Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa.

Kidney international·2007

Related Experiment Video

Updated: Feb 10, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

1.2K

Urinary tract infections revisited.

G Godaly1, C Svanborg

  • 1Institute of Laboratory Medicine, Department of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden.

Kidney International
|April 13, 2007
PubMed
Summary

Urinary tract infections (UTIs) are a persistent issue. Novel molecular tools can modernize UTI diagnosis and therapy by targeting bacterial virulence and host resistance factors.

Area of Science:

  • Urology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Urinary tract infections (UTIs) represent a significant and ongoing clinical challenge.
  • Current treatments, including antibiotics and surgical interventions, have limitations in fully resolving UTIs.
  • The molecular basis of bacterial virulence and host defense in UTIs is increasingly understood.

Purpose of the Study:

  • To propose the application of novel molecular tools for the diagnosis and therapy of UTIs.
  • To advocate for a modernized and individualized approach to UTI management.
  • To leverage current understanding of molecular determinants in UTI pathogenesis.

Main Methods:

  • Review of existing knowledge on bacterial virulence factors in UTIs.
  • Assessment of host resistance mechanisms at the molecular level.

More Related Videos

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging
07:39

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

3.5K
Transurethral Induction of Mouse Urinary Tract Infection
09:24

Transurethral Induction of Mouse Urinary Tract Infection

Published on: August 5, 2010

37.4K

Related Experiment Videos

Last Updated: Feb 10, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

1.2K
Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging
07:39

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

3.5K
Transurethral Induction of Mouse Urinary Tract Infection
09:24

Transurethral Induction of Mouse Urinary Tract Infection

Published on: August 5, 2010

37.4K
  • Exploration of emerging molecular detection technologies.

    • Main Results:

    • Identification of key molecular determinants of bacterial virulence.
    • Understanding of host resistance factors relevant to UTI.
    • Feasibility of applying advanced detection technologies.

    Conclusions:

    • Novel molecular tools offer a pathway to enhance UTI diagnosis.
    • Personalized therapeutic strategies for UTIs can be developed.
    • Advancements in molecular detection are crucial for future UTI management.